Theravance, Inc. (NASDAQ:THRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Recs

0
Player Avatar naughtyguy (61.18) Submitted: 8/19/2011 5:29:19 AM : Underperform Start Price: $17.32 THRX Score: -0.15

high market cap unjustified

Featured Broker Partners


Advertisement